Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Ebola Virus Entry: From Molecular Characterization to Drug Discovery.

Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palù G.

Viruses. 2019 Mar 19;11(3). pii: E274. doi: 10.3390/v11030274. Review.

2.

Freeze-dried matrices based on polyanion polymers for chlorhexidine local release in the buccal and vaginal cavities.

Giordani B, Abruzzo A, Musazzi UM, Cilurzo F, Nicoletta FP, Dalena F, Parolin C, Vitali B, Cerchiara T, Luppi B, Bigucci F.

J Pharm Sci. 2019 Mar 7. pii: S0022-3549(19)30144-3. doi: 10.1016/j.xphs.2019.02.026. [Epub ahead of print]

PMID:
30853513
3.

Perspectives on immunotherapy via oncolytic viruses.

Reale A, Vitiello A, Conciatori V, Parolin C, Calistri A, Palù G.

Infect Agent Cancer. 2019 Feb 11;14:5. doi: 10.1186/s13027-018-0218-1. eCollection 2019. Review.

4.

Univariate Statistical Analysis as a Guide to ¹H-NMR Spectra Signal Assignment by Visual Inspection.

Zhu C, Vitali B, Donders G, Parolin C, Li Y, Laghi L.

Metabolites. 2019 Jan 15;9(1). pii: E15. doi: 10.3390/metabo9010015.

5.

Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections.

Patrignani F, Siroli L, Parolin C, Serrazanetti DI, Vitali B, Lanciotti R.

PLoS One. 2019 Jan 9;14(1):e0208906. doi: 10.1371/journal.pone.0208906. eCollection 2019.

6.

Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS).

Le Grice S, Maccioni E, Corona A, Parolin C, Tramontano E.

Antiviral Res. 2019 Feb;162:110-117. doi: 10.1016/j.antiviral.2018.12.013. Epub 2018 Dec 23. Review.

PMID:
30586561
7.

Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells.

Parolin C, Frisco G, Foschi C, Giordani B, Salvo M, Vitali B, Marangoni A, Calonghi N.

Front Microbiol. 2018 Nov 6;9:2630. doi: 10.3389/fmicb.2018.02630. eCollection 2018.

8.

Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets.

Giordani B, Melgoza LM, Parolin C, Foschi C, Marangoni A, Abruzzo A, Dalena F, Cerchiara T, Bigucci F, Luppi B, Vitali B.

Int J Pharm. 2018 Oct 25;550(1-2):455-462. doi: 10.1016/j.ijpharm.2018.09.003. Epub 2018 Sep 5.

PMID:
30195082
9.

Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis.

Parolin C, Foschi C, Laghi L, Zhu C, Banzola N, Gaspari V, D'Antuono A, Giordani B, Severgnini M, Consolandi C, Salvo M, Cevenini R, Vitali B, Marangoni A.

Front Microbiol. 2018 Mar 28;9:600. doi: 10.3389/fmicb.2018.00600. eCollection 2018.

10.

Amiodarone affects Ebola virus binding and entry into target cells.

Salata C, Munegato D, Martelli F, Parolin C, Calistri A, Baritussio A, Palù G.

New Microbiol. 2018 Apr;41(2):162-164. Epub 2018 Mar 2.

11.

Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study.

Foschi C, Salvo M, Cevenini R, Parolin C, Vitali B, Marangoni A.

Front Cell Infect Microbiol. 2017 Dec 6;7:502. doi: 10.3389/fcimb.2017.00502. eCollection 2017.

12.

Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.

Trinchieri V, Laghi L, Vitali B, Parolin C, Giusti I, Capobianco D, Mastromarino P, De Simone C.

Front Immunol. 2017 Nov 6;8:1474. doi: 10.3389/fimmu.2017.01474. eCollection 2017.

13.

Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent.

Abruzzo A, Giordani B, Parolin C, Vitali B, Protti M, Mercolini L, Cappelletti M, Fedi S, Bigucci F, Cerchiara T, Luppi B.

Eur J Pharm Sci. 2018 Jan 15;112:95-101. doi: 10.1016/j.ejps.2017.11.012. Epub 2017 Nov 11.

PMID:
29138104
14.

Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity.

Biagioli M, Laghi L, Carino A, Cipriani S, Distrutti E, Marchianò S, Parolin C, Scarpelli P, Vitali B, Fiorucci S.

Front Pharmacol. 2017 Jul 28;8:505. doi: 10.3389/fphar.2017.00505. eCollection 2017.

15.

Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants.

Parolin C, Giordani B, Ñahui Palomino RA, Biagi E, Severgnini M, Consolandi C, Caredda G, Storelli S, Strohmenger L, Vitali B.

Sci Rep. 2017 Jul 24;7(1):6280. doi: 10.1038/s41598-017-06743-6.

16.

Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.

Esposito F, Mandrone M, Del Vecchio C, Carli I, Distinto S, Corona A, Lianza M, Piano D, Tacchini M, Maccioni E, Cottiglia F, Saccon E, Poli F, Parolin C, Tramontano E.

Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx065.

PMID:
28637198
17.

Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane.

Calonghi N, Parolin C, Sartor G, Verardi L, Giordani B, Frisco G, Marangoni A, Vitali B.

Benef Microbes. 2017 Aug 24;8(4):625-633. doi: 10.3920/BM2016.0212. Epub 2017 Jun 16.

PMID:
28618863
18.

Antiviral activity of cationic amphiphilic drugs.

Salata C, Calistri A, Parolin C, Baritussio A, Palù G.

Expert Rev Anti Infect Ther. 2017 May;15(5):483-492. doi: 10.1080/14787210.2017.1305888. Epub 2017 Mar 20. Review.

PMID:
28286997
19.

Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.

Siroli L, Patrignani F, Serrazanetti DI, Parolin C, Ñahui Palomino RA, Vitali B, Lanciotti R.

Front Microbiol. 2017 Feb 7;8:166. doi: 10.3389/fmicb.2017.00166. eCollection 2017.

20.

Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR.

Foschi C, Laghi L, Parolin C, Giordani B, Compri M, Cevenini R, Marangoni A, Vitali B.

PLoS One. 2017 Feb 16;12(2):e0172483. doi: 10.1371/journal.pone.0172483. eCollection 2017.

21.

Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia.

Parmeggiani F, Barbaro V, De Nadai K, Lavezzo E, Toppo S, Chizzolini M, Palù G, Parolin C, Di Iorio E.

Sci Rep. 2016 Dec 20;6:39179. doi: 10.1038/srep39179.

22.

Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS).

Le Grice SF, Sztuba-Solinska J, Maccioni E, Purzycka KJ, Parolin C, Tramontano E.

Antiviral Res. 2017 Mar;139:13-17. doi: 10.1016/j.antiviral.2016.12.004. Epub 2016 Dec 8.

23.

Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation.

Parmeggiani F, Barbaro V, Migliorati A, Raffa P, Nespeca P, De Nadai K, Del Vecchio C, Palù G, Parolin C, Di Iorio E.

Eur J Ophthalmol. 2017 Mar 10;27(2):240-248. doi: 10.5301/ejo.5000879. Epub 2016 Oct 21.

PMID:
27768226
24.

Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication.

Esposito F, Carli I, Del Vecchio C, Xu L, Corona A, Grandi N, Piano D, Maccioni E, Distinto S, Parolin C, Tramontano E.

Phytomedicine. 2016 Nov 15;23(12):1383-1391. doi: 10.1016/j.phymed.2016.08.001. Epub 2016 Aug 10.

PMID:
27765358
25.

Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.

Nardini P, Ñahui Palomino RA, Parolin C, Laghi L, Foschi C, Cevenini R, Vitali B, Marangoni A.

Sci Rep. 2016 Jun 29;6:29024. doi: 10.1038/srep29024.

26.

Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, Landini MP, Sekeyova Z, Dumler JS, Bădescu D, Busquets N, Calistri A, Parolin C, Palù G, Christova I, Maurin M, La Scola B, Raoult D.

Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1247-58. doi: 10.1007/s10096-016-2657-1. Epub 2016 May 27.

PMID:
27234593
27.

Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

Barbaro V, Nasti AA, Raffa P, Migliorati A, Nespeca P, Ferrari S, Palumbo E, Bertolin M, Breda C, Miceli F, Russo A, Caenazzo L, Ponzin D, Palù G, Parolin C, Di Iorio E.

Stem Cells Transl Med. 2016 Aug;5(8):1098-105. doi: 10.5966/sctm.2015-0358. Epub 2016 May 5.

28.

Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach.

Spanevello F, Calistri A, Del Vecchio C, Mantelli B, Frasson C, Basso G, Palù G, Cavazzana M, Parolin C.

Mol Ther Nucleic Acids. 2016 Apr 19;5:e312. doi: 10.1038/mtna.2016.24.

29.

Microparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycin.

Cerchiara T, Abruzzo A, Parolin C, Vitali B, Bigucci F, Gallucci MC, Nicoletta FP, Luppi B.

Carbohydr Polym. 2016 Jun 5;143:124-30. doi: 10.1016/j.carbpol.2016.02.020. Epub 2016 Feb 9.

PMID:
27083351
30.

Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function.

Barbaro V, Nasti AA, Del Vecchio C, Ferrari S, Migliorati A, Raffa P, Lariccia V, Nespeca P, Biasolo M, Willoughby CE, Ponzin D, Palù G, Parolin C, Di Iorio E.

Stem Cells. 2016 Jun;34(6):1588-600. doi: 10.1002/stem.2343. Epub 2016 Mar 16.

31.

Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.

Sosic A, Sinigaglia L, Cappellini M, Carli I, Parolin C, Zagotto G, Sabatino G, Rovero P, Fabris D, Gatto B.

Bioconjug Chem. 2016 Jan 20;27(1):247-56. doi: 10.1021/acs.bioconjchem.5b00627. Epub 2015 Dec 24.

32.

Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert.

Vitali B, Abruzzo A, Parolin C, Palomino RA, Dalena F, Bigucci F, Cerchiara T, Luppi B.

Carbohydr Polym. 2016 Jan 20;136:1161-9. doi: 10.1016/j.carbpol.2015.10.035. Epub 2015 Oct 22.

PMID:
26572459
33.

Amiodarone increases positive-strand RNA virus replication in vitro: implications for its use in patients with viral infections.

Salata C, Munegato D, Piccoli E, Calistri A, Parolin C, Mirazimi A, Baritussio A, Palù G.

J Antimicrob Chemother. 2016 Jan;71(1):280-1. doi: 10.1093/jac/dkv305. Epub 2015 Oct 1. No abstract available.

PMID:
26429565
34.

Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.

Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L.

Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2367-76. doi: 10.1007/s10096-015-2490-y. Epub 2015 Sep 18.

PMID:
26385347
35.

Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.

Parolin C, Marangoni A, Laghi L, Foschi C, Ñahui Palomino RA, Calonghi N, Cevenini R, Vitali B.

PLoS One. 2015 Jun 22;10(6):e0131220. doi: 10.1371/journal.pone.0131220. eCollection 2015.

36.

Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication.

Martelli F, Salata C, Calistri A, Parolin C, Azzi A, Palù G, Giannecchini S.

J Biotechnol. 2015 Sep 20;210:85-90. doi: 10.1016/j.jbiotec.2015.06.391. Epub 2015 Jun 16.

PMID:
26091771
37.

Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.

Salata C, Baritussio A, Munegato D, Calistri A, Ha HR, Bigler L, Fabris F, Parolin C, Palù G, Mirazimi A.

Pathog Dis. 2015 Jul;73(5). pii: ftv032. doi: 10.1093/femspd/ftv032. Epub 2015 Apr 30.

PMID:
25933611
38.

Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.

Cerchiara T, Abruzzo A, di Cagno M, Bigucci F, Bauer-Brandl A, Parolin C, Vitali B, Gallucci MC, Luppi B.

Eur J Pharm Biopharm. 2015 May;92:112-9. doi: 10.1016/j.ejpb.2015.03.004. Epub 2015 Mar 11.

PMID:
25769679
39.

Autochthonous Hookworm-Related Cutaneous Larva Migrans Disease in Northeastern Italy: A Case Report.

Akkouche W, Ahmed SA, Sattin A, Piaserico S, Calistri A, De Canale E, Parolin C.

J Parasitol. 2015 Aug;101(4):488-9. doi: 10.1645/15-725.1. Epub 2015 Mar 12.

PMID:
25764145
40.

From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors.

Xu L, Grandi N, Del Vecchio C, Mandas D, Corona A, Piano D, Esposito F, Parolin C, Tramontano E.

J Microbiol. 2015 Apr;53(4):288-93. doi: 10.1007/s12275-015-4652-0. Epub 2015 Mar 4.

PMID:
25740376
41.

Functional Interaction Between the ESCRT-I Component TSG101 and the HSV-1 Tegument Ubiquitin Specific Protease.

Calistri A, Munegato D, Toffoletto M, Celestino M, Franchin E, Comin A, Sartori E, Salata C, Parolin C, Palù G.

J Cell Physiol. 2015 Aug;230(8):1794-806. doi: 10.1002/jcp.24890.

PMID:
25510868
42.

Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.

Meleddu R, Cannas V, Distinto S, Sarais G, Del Vecchio C, Esposito F, Bianco G, Corona A, Cottiglia F, Alcaro S, Parolin C, Artese A, Scalise D, Fresta M, Arridu A, Ortuso F, Maccioni E, Tramontano E.

ChemMedChem. 2014 Aug;9(8):1869-79. doi: 10.1002/cmdc.201402015. Epub 2014 May 21.

PMID:
24850787
43.

The ubiquitin-conjugating system: multiple roles in viral replication and infection.

Calistri A, Munegato D, Carli I, Parolin C, Palù G.

Cells. 2014 May 6;3(2):386-417. doi: 10.3390/cells3020386.

44.

Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo.

Elbadawy HM, Gailledrat M, Desseaux C, Salvalaio G, Di Iorio E, Ferrari B, Bertolin M, Barbaro V, Parekh M, Gayon R, Munegato D, Franchin E, Calistri A, Palù G, Parolin C, Ponzin D, Ferrari S.

Gene Ther. 2014 Mar;21(3):272-81. doi: 10.1038/gt.2013.82. Epub 2014 Jan 16.

PMID:
24430237
45.

New generation sequencing in pathogen discovery and microbial surveillance.

Calistri A, Salata C, Parolin C, Palù G.

Expert Rev Anti Infect Ther. 2013 Sep;11(9):877-9. doi: 10.1586/14787210.2013.827883.

PMID:
24053269
46.

Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities.

Esposito F, Sanna C, Del Vecchio C, Cannas V, Venditti A, Corona A, Bianco A, Serrilli AM, Guarcini L, Parolin C, Ballero M, Tramontano E.

Pathog Dis. 2013 Aug;68(3):116-24. doi: 10.1111/2049-632X.12051. Epub 2013 Jul 2.

PMID:
23821410
47.

A peptidic hydrogel that may behave as a "Trojan Horse".

Castellucci N, Sartor G, Calonghi N, Parolin C, Falini G, Tomasini C.

Beilstein J Org Chem. 2013;9:417-24. doi: 10.3762/bjoc.9.44. Epub 2013 Feb 22.

48.

Tsg101 interacts with herpes simplex virus 1 VP1/2 and is a substrate of VP1/2 ubiquitin-specific protease domain activity.

Caduco M, Comin A, Toffoletto M, Munegato D, Sartori E, Celestino M, Salata C, Parolin C, Palù G, Calistri A.

J Virol. 2013 Jan;87(1):692-6. doi: 10.1128/JVI.01969-12. Epub 2012 Oct 17. Retraction in: J Virol. 2013 Jun;87(11):6537.

49.

Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer.

Parolin C, Calonghi N, Presta E, Boga C, Caruana P, Naldi M, Andrisano V, Masotti L, Sartor G.

Biochim Biophys Acta. 2012 Oct;1821(10):1334-40. doi: 10.1016/j.bbalip.2012.07.007. Epub 2012 Jul 17.

PMID:
22814230
50.

A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: implications for recurrence risk and prenatal diagnosis.

Barbaro V, Nardiello P, Castaldo G, Willoughby CE, Ferrari S, Ponzin D, Amato F, Bonifazi E, Parekh M, Calistri A, Parolin C, Di Iorio E.

Am J Med Genet A. 2012 Aug;158A(8):1957-61. doi: 10.1002/ajmg.a.35414. Epub 2012 Jun 27.

PMID:
22740388

Supplemental Content

Loading ...
Support Center